Royce & Associates LP Harrow Health, Inc. Transaction History
Royce & Associates LP
- $10.5 Billion
- Q3 2024
A detailed history of Royce & Associates LP transactions in Harrow Health, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 360,320 shares of HROW stock, worth $13.2 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
360,320
Previous 539,900
33.26%
Holding current value
$13.2 Million
Previous $11.3 Million
43.63%
% of portfolio
0.15%
Previous 0.11%
Shares
6 transactions
Others Institutions Holding HROW
# of Institutions
177Shares Held
21.4MCall Options Held
845KPut Options Held
717K-
Opaleye Management Inc. Boston, MA3.99MShares$146 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$79.3 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$78.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$68.4 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$26.8 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $992M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...